<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21396941</PMID><DateCompleted><Year>2011</Year><Month>06</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1089-8638</ISSN><JournalIssue CitedMedium="Internet"><Volume>408</Volume><Issue>3</Issue><PubDate><Year>2011</Year><Month>May</Month><Day>06</Day></PubDate></JournalIssue><Title>Journal of molecular biology</Title><ISOAbbreviation>J Mol Biol</ISOAbbreviation></Journal><ArticleTitle>Crystal structure of human enterovirus 71 3C protease.</ArticleTitle><Pagination><StartPage>449</StartPage><EndPage>461</EndPage><MedlinePgn>449-61</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jmb.2011.03.007</ELocationID><Abstract><AbstractText>Human enterovirus 71 (EV71) is the major pathogen that causes hand, foot and mouth disease that particularly affects young children. Growing hand, foot and mouth disease outbreaks were observed worldwide in recent years and caused devastating losses both economically and politically. However, vaccines or effective drugs are unavailable to date. The genome of EV71 consists of a positive sense, single-stranded RNA of &#x223c;7400 bp, encoding a large precursor polyprotein that requires proteolytic processing to generate mature viral proteins. The proteolytic processing mainly depends on EV71 3C protease (3C(pro)) that possesses both proteolysis and RNA binding activities, which enable the protease to perform multiple tasks in viral replication and pathogen-host interactions. The central roles played by EV71 3C(pro) make it an appealing target for antiviral drug development. We determined the first crystal structure of EV71 3C(pro) and analyzed its enzymatic activity. The crystal structure shows that EV71 3C(pro) has a typical chymotrypsin-like fold that is common in picornaviral 3C(pro). Strikingly, we found an important surface loop, also denoted as &#x3b2;-ribbon, which adopts a novel open conformation in EV71 3C(pro). We identified two important residues located at the base of the &#x3b2;-ribbon, Gly123 and His133, which form hinges that govern the intrinsic flexibility of the ribbon. Structure-guided mutagenesis studies revealed that the hinge residues are important to EV71 3C(pro) proteolytic activities. In summary, our work provides the first structural insight into EV71 3C(pro), including a mobile &#x3b2;-ribbon, which is relevant to the proteolytic mechanism. Our data also provides a framework for structure-guided inhibitor design against EV71 3C(pro).</AbstractText><CopyrightInformation>Copyright &#xa9; 2011 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Sheng</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>State Key Laboratory for Molecular Virology and Genetic Engineering, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, People's Republic of China. cuisheng2007@yahoo.com.cn</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jing</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Tingting</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Bo</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Li</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Lei</LastName><ForeName>Xiaobo</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jianwei</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Meitian</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Qi</ForeName><Initials>Q</Initials></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>GENBANK</DataBankName><AccessionNumberList><AccessionNumber>HQ615421</AccessionNumber></AccessionNumberList></DataBank><DataBank><DataBankName>PDB</DataBankName><AccessionNumberList><AccessionNumber>3OSY</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>03</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Mol Biol</MedlineTA><NlmUniqueID>2985088R</NlmUniqueID><ISSNLinking>0022-2836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D003546">Cysteine Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.28</RegistryNumber><NameOfSubstance UI="D000086042">3C Viral Proteases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086042" MajorTopicYN="N">3C Viral Proteases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018360" MajorTopicYN="N">Crystallography, X-Ray</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003546" MajorTopicYN="N">Cysteine Endopeptidases</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016297" MajorTopicYN="N">Mutagenesis, Site-Directed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017434" MajorTopicYN="N">Protein Structure, Tertiary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017422" MajorTopicYN="N">Sequence Analysis, DNA</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017386" MajorTopicYN="N">Sequence Homology, Amino Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2010</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2011</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2011</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>6</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2011</Year><Month>3</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21396941</ArticleId><ArticleId IdType="pmc">PMC7094522</ArticleId><ArticleId IdType="doi">10.1016/j.jmb.2011.03.007</ArticleId><ArticleId IdType="pii">S0022-2836(11)00260-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chen C.Y., Chang Y.C., Huang C.C., Lui C.C., Lee K.W., Huang S.C. Acute flaccid paralysis in infants and young children with enterovirus 71 infection: MR imaging findings and clinical correlates. Am. J. Neuroradiol. 2001;22:200&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7975539</ArticleId><ArticleId IdType="pubmed">11158910</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee T.C., Guo H.R., Su H.J., Yang Y.C., Chang H.L., Chen K.T. Diseases caused by enterovirus 71 infection. Pediatr. Infect. Dis. J. 2009;28:904&#x2013;910.</Citation><ArticleIdList><ArticleId IdType="pubmed">20118685</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P., Stratov I., Nagarajan L., Davis S. Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin. Infect. Dis. 2001;32:236&#x2013;242.</Citation><ArticleIdList><ArticleId IdType="pubmed">11170913</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho M., Chen E.R., Hsu K.H., Twu S.J., Chen K.T., Tsai S.F. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N. Engl. J. Med. 1999;341:929&#x2013;935.</Citation><ArticleIdList><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S.B., Liao H., Huang C.H., Tan Q.Y., Zhang W.L., Huang Y. [Serum types of enterovirus and clinical characteristics of 237 children with hand, foot and mouth disease in Shenzhen] Zhongguo Dangdai ErKe ZaZhi. 2008;10:38&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">18289469</ArticleId></ArticleIdList></Reference><Reference><Citation>AbuBakar S., Chee H.Y., Al-Kobaisi M.F., Xiaoshan J., Chua K.B., Lam S.K. Identification of enterovirus 71 isolates from an outbreak of hand, foot and mouth disease (HFMD) with fatal cases of encephalomyelitis in Malaysia. Virus Res. 1999;61:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">10426204</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander J.P., Jr., Baden L., Pallansch M.A., Anderson L.J. Enterovirus 71 infections and neurologic disease&#x2014;United States, 1977&#x2013;1991. J. Infect. Dis. 1994;169:905&#x2013;908.</Citation><ArticleIdList><ArticleId IdType="pubmed">8133108</ArticleId></ArticleIdList></Reference><Reference><Citation>Kehle J., Roth B., Metzger C., Pfitzner A., Enders G. Molecular characterization of an Enterovirus 71 causing neurological disease in Germany. J. NeuroVirol. 2003;9:126&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pubmed">12587076</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan, Central China province reports surge in HFMD deaths http://news.xinhuanet.com/english, 2010.</Citation></Reference><Reference><Citation>The Chinese Center for Disease Control and Prevention, and the World Health Organization, Report on the Hand, Foot and Mouth Disease Outbreak in Fuyang City, Anhui Province and the Prevention and Control in China (May 2008) World Health Organization Representative Office in China, 2008.</Citation></Reference><Reference><Citation>Zhang D., Lu J., Lu J. Enterovirus 71 vaccine: close but still far. Int. J. Infect. Dis. 2010;14:e739&#x2013;e743.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7110504</ArticleId><ArticleId IdType="pubmed">20400350</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F., Jin Q., He Y., Li L., Hou Y. The complete genome of Enterovirus 71 China strain. Sci. China, Ser. C: Life Sci. 2001;44:178&#x2013;183.</Citation><ArticleIdList><ArticleId IdType="pubmed">18726435</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang Y.C., Chen W., Yates M.V. Use of fluorescence resonance energy transfer for rapid detection of enteroviral infection in vivo. Appl. Environ. Microbiol. 2006;72:3710&#x2013;3715.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1472337</ArticleId><ArticleId IdType="pubmed">16672521</ArticleId></ArticleIdList></Reference><Reference><Citation>Bishop N.E., Anderson D.A. RNA-dependent cleavage of VP0 capsid protein in provirions of hepatitis A virus. Virology. 1993;197:616&#x2013;623.</Citation><ArticleIdList><ArticleId IdType="pubmed">8249284</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng K.F., Li M.L., Hung C.T., Shih S.R. Enterovirus 71 3C protease cleaves a novel target CstF-64 and inhibits cellular polyadenylation. PLoS Pathog. 2009;5:e1000593.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2742901</ArticleId><ArticleId IdType="pubmed">19779565</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo C.J., Shie J.J., Fang J.M., Yen G.R., Hsu J.T., Liu H.G. Design, synthesis, and evaluation of 3C protease inhibitors as anti-enterovirus 71 agents. Bioorg. Med. Chem. 2008;16:7388&#x2013;7398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7125518</ArticleId><ArticleId IdType="pubmed">18583140</ArticleId></ArticleIdList></Reference><Reference><Citation>Birtley J.R., Knox S.R., Jaulent A.M., Brick P., Leatherbarrow R.J., Curry S. Crystal structure of foot-and-mouth disease virus 3C protease. New insights into catalytic mechanism and cleavage specificity. J. Biol. Chem. 2005;280:11520&#x2013;11527.</Citation><ArticleIdList><ArticleId IdType="pubmed">15654079</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney T.R., Roqu&#xe9;-Rosell N., Birtley J.R., Leatherbarrow R.J., Curry S. Structural and mutagenic analysis of foot-and-mouth disease virus 3C protease reveals the role of the beta-ribbon in proteolysis. J. Virol. 2007;81:115&#x2013;124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1797255</ArticleId><ArticleId IdType="pubmed">17065215</ArticleId></ArticleIdList></Reference><Reference><Citation>Zunszain P.A., Knox S.R., Sweeney T.R., Yang J., Roqu&#xe9;-Rosell N., Belsham G.J. Insights into cleavage specificity from the crystal structure of foot-and-mouth disease virus 3C protease complexed with a peptide substrate. J. Mol. Biol. 2009;395:375&#x2013;389.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7099390</ArticleId><ArticleId IdType="pubmed">19883658</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee C.C., Kuo C.J., Ko T.P., Hsu M.F., Tsui Y.C., Chang S.C. Structural basis of inhibition specificities of 3C and 3C-like proteases by zinc-coordinating and peptidomimetic compounds. J. Biol. Chem. 2009;284:7646&#x2013;7655.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2658058</ArticleId><ArticleId IdType="pubmed">19144641</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuhrmann C.N., Kelch B.A., Ota N., Agard D.A. The 0.83&#xa0;&#xc5; resolution crystal structure of alpha-lytic protease reveals the detailed structure of the active site and identifies a source of conformational strain. J. Mol. Biol. 2004;338:999&#x2013;1013.</Citation><ArticleIdList><ArticleId IdType="pubmed">15111063</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthews D.A., Dragovich P.S., Webber S.E., Fuhrman S.A., Patick A.K., Zalman L.S. Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes. Proc. Natl Acad. Sci. USA. 1999;96:11000&#x2013;11007.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC34232</ArticleId><ArticleId IdType="pubmed">10500114</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopfner K.P., Lang A., Karcher A., Sichler K., Kopetzki E., Brandstetter H. Coagulation factor IXa: the relaxed conformation of Tyr99 blocks substrate binding. Structure. 1999;7:989&#x2013;996.</Citation><ArticleIdList><ArticleId IdType="pubmed">10467148</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergmann E.M., Cherney M.M., Mckendrick J., Frormann S., Luo C., Malcolm B.A. Crystal structure of an inhibitor complex of the 3C proteinase from hepatitis A virus (HAV) and implications for the polyprotein processing in HAV. Virology. 1999;265:153&#x2013;163.</Citation><ArticleIdList><ArticleId IdType="pubmed">10603326</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosimann S.C., Cherney M.M., Sia S., Plotch S., James M.N. Refined X-ray crystallographic structure of the poliovirus 3C gene product. J. Mol. Biol. 1997;273:1032&#x2013;1047.</Citation><ArticleIdList><ArticleId IdType="pubmed">9367789</ArticleId></ArticleIdList></Reference><Reference><Citation>Allaire M., Chernaia M.M., Malcolm B.A., James M.N. Picornaviral 3C cysteine proteinases have a fold similar to chymotrypsin-like serine proteinases. Nature. 1994;369:72&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">8164744</ArticleId></ArticleIdList></Reference><Reference><Citation>Phan J., Zdanov A., Evdokimov A.G., Tropea J.E., Peters H.K., 3rd, Kapust R.B. Structural basis for the substrate specificity of tobacco etch virus protease. J. Biol. Chem. 2002;277:50564&#x2013;50572.</Citation><ArticleIdList><ArticleId IdType="pubmed">12377789</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujinaga M., Delbaere L.T., Brayer G.D., James M.N. Refined structure of alpha-lytic protease at 1.7&#xa0;&#xc5; resolution. Analysis of hydrogen bonding and solvent structure. J. Mol. Biol. 1985;184:479&#x2013;502.</Citation><ArticleIdList><ArticleId IdType="pubmed">3900416</ArticleId></ArticleIdList></Reference><Reference><Citation>James M.N., Sielecki A.R., Brayer G.D., Delbaere L.T., Bauer C.A. Structures of product and inhibitor complexes of Streptomyces griseus protease A at 1.8&#xa0;&#xc5; resolution. A model for serine protease catalysis. J. Mol. Biol. 1980;144:43&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">6783761</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujinaga M., Read R.J., Sielecki A., Ardelt W., Laskowski M., Jr, James M.N. Refined crystal structure of the molecular complex of Streptomyces griseus protease B, a serine protease, with the third domain of the ovomucoid inhibitor from turkey. Proc. Natl Acad. Sci. USA. 1982;79:4868&#x2013;4872.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC346786</ArticleId><ArticleId IdType="pubmed">6750612</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih S.R., Chiang C., Chen T.C., Wu C.N., Hsu J.T., Lee J.C. Mutations at KFRDI and VGK domains of enterovirus 71 3C protease affect its RNA binding and proteolytic activities. J. Biomed. Sci. 2004;11:239&#x2013;248.</Citation><ArticleIdList><ArticleId IdType="pubmed">14966374</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters H., Kusov Y.Y., Meyer S., Benie A.J., B&#xe4;uml E., Wolff M. Hepatitis A virus proteinase 3C binding to viral RNA: correlation with substrate binding and enzyme dimerization. Biochem. J. 2005;385:363&#x2013;370.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1134706</ArticleId><ArticleId IdType="pubmed">15361063</ArticleId></ArticleIdList></Reference><Reference><Citation>Kusov Y.Y., Gauss-Muller V. In vitro RNA binding of the hepatitis A virus proteinase 3C (HAV 3Cpro) to secondary structure elements within the 5&#x2032; terminus of the HAV genome. RNA. 1997;3:291&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1369481</ArticleId><ArticleId IdType="pubmed">9056766</ArticleId></ArticleIdList></Reference><Reference><Citation>Andino R., Rieckhof G.E., Achacoso P.L., Baltimore D. Poliovirus RNA synthesis utilizes an RNP complex formed around the 5&#x2032;-end of viral RNA. EMBO J. 1993;12:3587&#x2013;3598.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC413634</ArticleId><ArticleId IdType="pubmed">8253083</ArticleId></ArticleIdList></Reference><Reference><Citation>Parsley T.B., Towner J.S., Blyn L.B., Ehrenfeld E., Semler B.L. Poly (rC) binding protein 2 forms a ternary complex with the 5&#x2032;-terminal sequences of poliovirus RNA and the viral 3CD proteinase. RNA. 1997;3:1124&#x2013;1134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1369554</ArticleId><ArticleId IdType="pubmed">9326487</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris K.S., Reddigari S.R., Nicklin M.J., H&#xe4;mmerle T., Wimmer E. Purification and characterization of poliovirus polypeptide 3CD, a proteinase and a precursor for RNA polymerase. J. Virol. 1992;66:7481&#x2013;7489.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC240456</ArticleId><ArticleId IdType="pubmed">1331532</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthews D.A., Smith W.W., Ferre R.A., Condon B., Budahazi G., Sisson W. Structure of human rhinovirus 3C protease reveals a trypsin-like polypeptide fold, RNA-binding site, and means for cleaving precursor polyprotein. Cell. 1994;77:761&#x2013;771.</Citation><ArticleIdList><ArticleId IdType="pubmed">7515772</ArticleId></ArticleIdList></Reference><Reference><Citation>Leong L.E., Walker P.A., Porter A.G. Human rhinovirus-14 protease 3C (3Cpro) binds specifically to the 5&#x2032;-noncoding region of the viral RNA. Evidence that 3Cpro has different domains for the RNA binding and proteolytic activities. J. Biol. Chem. 1993;268:25735&#x2013;25739.</Citation><ArticleIdList><ArticleId IdType="pubmed">8245010</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker P.A., Leong L.E., Porter A.G. Sequence and structural determinants of the interaction between the 5&#x2032;-noncoding region of picornavirus RNA and rhinovirus protease 3C. J. Biol. Chem. 1995;270:14510&#x2013;14516.</Citation><ArticleIdList><ArticleId IdType="pubmed">7782313</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X.N., Song Z.G., Jiang T., Shi B.S., Hu Y.W., Yuan Z.H. Rupintrivir is a promising candidate for treating severe cases of Enterovirus-71 infection. World J. Gastroenterol. 2010;16:201&#x2013;209.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2806558</ArticleId><ArticleId IdType="pubmed">20066739</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabsch W. XDS. Acta Crystallogr., Sect. D: Biol. Crystallogr. 2010;66:125&#x2013;132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2815665</ArticleId><ArticleId IdType="pubmed">20124692</ArticleId></ArticleIdList></Reference><Reference><Citation>McCoy A.J., Grosse-Kunstleve R.W., Adams P.D., Winn M.D., Storoni L.C., Read R.J. Phaser crystallographic software. J. Appl. Crystallogr. 2007;40:658&#x2013;674.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2483472</ArticleId><ArticleId IdType="pubmed">19461840</ArticleId></ArticleIdList></Reference><Reference><Citation>Emsley P., Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr., Sect. D: Biol. Crystallogr. 2004;60:2126&#x2013;2132.</Citation><ArticleIdList><ArticleId IdType="pubmed">15572765</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams P.D., Afonine P.V., Bunk&#xf3;czi G., Chen V.B., Davis I.W., Echols N. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr., Sect. D: Biol. Crystallogr. 2010;66:213&#x2013;221.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2815670</ArticleId><ArticleId IdType="pubmed">20124702</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>